Amicus Therapeutics (FOLD) Current Leases (2016 - 2025)
Historic Current Leases for Amicus Therapeutics (FOLD) over the last 11 years, with Q3 2025 value amounting to $8.7 million.
- Amicus Therapeutics' Current Leases rose 141.67% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 141.67%. This contributed to the annual value of $8.5 million for FY2024, which is 157.38% up from last year.
- Amicus Therapeutics' Current Leases amounted to $8.7 million in Q3 2025, which was up 141.67% from $8.6 million recorded in Q2 2025.
- Over the past 5 years, Amicus Therapeutics' Current Leases peaked at $8.7 million during Q3 2025, and registered a low of $6.8 million during Q1 2021.
- In the last 5 years, Amicus Therapeutics' Current Leases had a median value of $8.0 million in 2023 and averaged $7.9 million.
- In the last 5 years, Amicus Therapeutics' Current Leases plummeted by 1655.71% in 2021 and then surged by 1542.72% in 2022.
- Amicus Therapeutics' Current Leases (Quarter) stood at $7.4 million in 2021, then increased by 15.43% to $8.6 million in 2022, then decreased by 2.67% to $8.3 million in 2023, then grew by 1.57% to $8.5 million in 2024, then rose by 2.45% to $8.7 million in 2025.
- Its Current Leases stands at $8.7 million for Q3 2025, versus $8.6 million for Q2 2025 and $8.6 million for Q1 2025.